ImmunoGen Competitors and Similar CompaniesClear all
ADC Therapeutics's competitors and similar companies include Ablynx.
 ADC Therapeutics ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |
Founding Date | Founding Date 2010 | Founding Date 2001 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Epalinges, CH HQ London, GB New Providence, US | Locations Gent, BE HQ |
Employees | Employees 1162% increase | Employees 1252% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $81.4m (FY, 2025) | Revenue (est.) €85.2m (FY, 2016) |
Net income | Net income ($142.6m) (FY, 2025) | Net income (€1.1m) (FY, 2016) |
Funding | ||
Total funding raised | Total funding raised $ 526m | Total funding raised $ 498.8m |
For sources of this data, please see the company profile
View Company Profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company